ADT Inc. has announced that it has entered into a definitive agreement to be acquired by Thrive Holdings in a transaction valued at $15.3 billion. This acquisition marks a significant milestone for ADT, a leading provider in the security services sector, as it aims to enhance its service offerings and technological capabilities.
The acquisition is expected to close in the first quarter of 2027, subject to customary closing conditions, including approval from ADT's stockholders and receipt of necessary regulatory approvals. Once the transaction is finalized, ADT will transition to operate as a private company.
Background
ADT Inc. is a prominent player in the security services industry, classified under the SIC code 7381, which encompasses detective, guard, and armored car services. The company is listed on the New York Stock Exchange under the ticker symbol ADT. ADT has a long-standing history of providing security solutions and has built a strong reputation based on its extensive experience and nationwide service network.
What the Filing Says
According to the recent SEC filing, ADT communicated to its vendors that it has entered into a definitive agreement to be acquired by Thrive Holdings. The company expressed excitement about this new chapter, highlighting that the acquisition would combine ADT's 150 years of security experience with Thrive's technological expertise. The filing states, "We are excited about this next chapter for ADT, which brings together our more than 150 years of security experience... with Thrive Holdings’ technology expertise and engineering capabilities."
Impact
This acquisition could significantly impact ADT's operations and its relationships with vendors and customers. The company reassured its vendors that existing agreements would remain unchanged and that it is committed to maintaining strong relationships during this transition. The collaboration with Thrive Holdings is expected to provide ADT with greater flexibility to invest in products and services, potentially enhancing customer satisfaction and operational efficiency.
What's Next
The transaction is set to close in the first quarter of 2027, pending stockholder approval and regulatory clearance. ADT plans to keep stakeholders informed of relevant developments as the acquisition process unfolds.
Read Next
Westlake BioPartners Discloses Major Stake in Latigo Biotherapeutics
Westlake BioPartners Acquires Significant Stake in Electra Therapeutics
Coletti Reports New Stock Transactions for Cintas Corp
Bain Capital Life Sciences acquires 9.99% stake in ADC Therapeutics
Studio City International Holdings reports major share transactions
Saba Capital Management acquires shares in New Germany Fund





